The alternatives
TRT Nation scores 59/100 (grade C, ranked #385) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to TRT Nation's 59, and our TRT Nation vs CoreAge Rx ruling sets the two out factor by factor.
TeleZen MD (telezenmd.com) is a fully online telehealth practice.
TeleZen MD matches TRT Nation at 59/100; our full write-up on TeleZen MD has the pricing conditions and the caveats in detail.
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
NuuVim matches TRT Nation at 59/100; the full NuuVim review has the pricing conditions and the caveats in detail.
SkyRx (sky-rx.co) is a US telehealth weight-loss program offering compounded semaglutide as an injection or oral drops, with compounded tirzepatide listed as coming soon.
SkyRx matches TRT Nation at 59/100; our full write-up on SkyRx has the pricing conditions and the caveats in detail.
Actin offers compounded semaglutide with B12 for weight loss.
Actin scores 58/100 to TRT Nation's 59; our full write-up on Actin has the pricing conditions and the caveats in detail.
Roen Rx offers compounded semaglutide as well as brand-name Ozempic, Wegovy, Zepbound, and Mounjaro with insurance coordination.
Roen Rx matches TRT Nation at 59/100; our full write-up on Roen Rx has the pricing conditions and the caveats in detail.
Men's health telehealth brand offering GLP-1 weight loss treatments.
Dollar Dad Club scores 58/100 to TRT Nation's 59; our full write-up on Dollar Dad Club has the pricing conditions and the caveats in detail.
See the complete rankings or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.